MA MPJE study materials
MA MPJE study resources

A Discount Semaglutide From an Unverified Supplier

MA MPJE · Put your knowledge to work in context.

All case studies

A Discount Semaglutide From an Unverified Supplier

A new buyer at an independent pharmacy receives a cold call from a distributor offering semaglutide at 30% below the primary wholesaler's price. The distributor emails a Massachusetts wholesale druggist license and an FDA registration number. The shipment arrives in a plain carton with a packing slip only - no transaction statement or transaction history - and one vial's label lot number does not match the packing slip. The buyer also discovers that the pharmacy's own Board license expired 11 days ago; the renewal was mailed but not processed. The buyer wants to dispense the product before the weekend rush.

1. May the pharmacy purchase from this distributor? What verification is required before any order is placed?

Read the worked answer

No - not until the trading partner is verified through independent sources.

  • Licensure: verify the Massachusetts wholesale druggist license and FDA registration directly with the Board/DPH and FDA, not from an emailed PDF. Confirm the license covers the products and the address actually shipping.
  • DSCSA eligibility: the pharmacy may only trade with authorized trading partners and must receive, at the transaction, the Transaction Information, Transaction History, and Transaction Statement demonstrating the chain of custody from the manufacturer. A packing slip is not a transaction document.
  • Due diligence: price far below market, cold-call solicitation, no prior relationship, and a secondary/repackager-only chain are textbook counterfeit or diverted-product indicators.
  • Your own status matters too: purchasing must come from a licensed source and be recorded; an unlicensed source exposes the pharmacy's license to discipline even if the product turns out to be genuine.

If the documentation cannot be produced and independently verified, the order does not get placed.

2. The product is now in the pharmacy, unsolicited and questionable. What must be done with it?

Read the worked answer

Quarantine, do not dispense, do not return to stock, and document the chain of custody.

  1. Segregate it immediately in a locked, labeled "do not dispense / suspect product" area with controlled access.
  2. Do not dispense or sell it, and do not return it to the supplier without instructions - returning suspect product can put it back into the supply chain.
  3. Notify the manufacturer and the FDA (suspect product/counterfeit reporting), and notify the trading partner. If the supplier is unlicensed, report that to the Board of Registration in Pharmacy.
  4. Record: retain the carton, packing slip, emails, licenses received, lot numbers, and a written timeline of who handled the product.
  5. Assess exposure: check whether any doses from this supplier have already been dispensed, and if so, identify patients, notify prescribers, and quarantine remaining stock.

The lot-number discrepancy alone is disqualifying - it means the transaction documentation does not match the physical product.

3. Separately, the pharmacy's license expired 11 days ago. What is the pharmacist's obligation today?

Read the worked answer

Stop dispensing until licensure is restored. "The renewal is in the mail" is not a license.

  • A pharmacy may not operate, and a pharmacist may not dispense, from a facility whose Board license has lapsed. Mailing a renewal does not extend the expiration date printed on the license.
  • The pharmacist-in-charge must contact the Board immediately, confirm the status, expedite renewal, and document the lapse window and any dispensing that occurred in it. The PIC is accountable for calendar tracking of the facility license and the controlled-substance registrations.
  • Check the other credentials separately: the Massachusetts Controlled Substances Registration and the DEA registration each run on their own cycle and are not cured by renewing the Board license. Dispensing controlled substances with an expired MCSR or DEA registration is a separate violation.
  • Practical steps: notify the owner, post the status, arrange for prescriptions to be transferred or held, and keep a written record. Continuing to dispense while unlicensed is unlicensed practice and a direct path to Board discipline.